Journal article · 2009 · Open access

NF-κB and Therapeutic Approach

Chang‐Hoon Lee, Soo‐Youl Kim

Biomolecules & Therapeutics, 17(3), 219–240 · Published 31 July 2009 · DOI 10.4062/biomolther.2009.17.3.219

Free PDFView at the publisherCite this paper

In brief

“NF-κB and Therapeutic Approach” is a 2009 journal article by Chang‐Hoon Lee and Soo‐Youl Kim, published in Biomolecules & Therapeutics. OpenAlex counts 14 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Biomolecules & Therapeutics.

Citations
14
Most cited in
2012 (3)
Field-weighted impact
1.06
References
139
Authors
2

Abstract

Since NF- ${\kappa}B$ has been identified as a transcription factor associated with immune cell activation, groups of researchers have dedicated to reveal detailed mechanisms of nuclear factor of ${\kappa}B$ (NF- ${\kappa}B$ ) in inflammatory signaling for decades. The various molecular components of NF- ${\kappa}B$ transcription factor pathway have been being evaluated as important therapeutic targets due to their roles in diverse human diseases including inflammation, cystic fibrosis, sepsis, rheumatoid arthritis, cancer, atherosclerosis, ischemic injury, myocardial infarction, osteoporosis, transplantation rejection, and neurodegeneration. With regards to new drugs directly or indirectly modulating the NF- ${\kappa}B$ pathway, FDA recently approved a proteasome inhibitor bortezomib for the treatment of multiple myeloma. Many pharmaceutical companies have been trying to develop new drugs to inhibit various kinases in the NF- ${\kappa}B$ signaling pathway for many therapeutic applications. However, a gene knock-out study for $IKK{\beta}$ in the NF- ${\kappa}B$ pathway has given rise to controversies associated with efficacy as therapeutics. Mice lacking hepatocyte $IKK{\beta}$ accelerated cancer instead of preventing progress of cancer. However, it is clear that pharmacological inhibition of $IKK{\beta}$ appears to be beneficial to reduce HCC. This article will update issues of the NF- ${\kappa}B$ pathway and inhibitors regulating this pathway.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Lee, C., & Kim, S. (2009). NF-κB and Therapeutic Approach. Biomolecules & Therapeutics, 17(3), 219–240. https://doi.org/10.4062/biomolther.2009.17.3.219

MLA 9

Lee, Chang‐Hoon, and Soo‐Youl Kim. “NF-κB and Therapeutic Approach.” Biomolecules & Therapeutics, vol. 17, no. 3, 2009, pp. 219–240. https://doi.org/10.4062/biomolther.2009.17.3.219.

Chicago

Lee, Chang‐Hoon and Soo‐Youl Kim. 2009. “NF-κB and Therapeutic Approach.” Biomolecules & Therapeutics 17 (3): 219–240. https://doi.org/10.4062/biomolther.2009.17.3.219.

Harvard

Lee, C. and Kim, S. (2009) ‘NF-κB and Therapeutic Approach’, Biomolecules & Therapeutics, 17(3), pp. 219–240. doi:10.4062/biomolther.2009.17.3.219.

IEEE

C. Lee and S. Kim, “NF-κB and Therapeutic Approach,” Biomolecules & Therapeutics, vol. 17, no. 3, pp. 219–240, 2009, doi: 10.4062/biomolther.2009.17.3.219.

BibTeX

@article{lee2009therapeutic,
  title     = {{NF-κB and Therapeutic Approach}},
  author    = {Lee, Chang‐Hoon and Kim, Soo‐Youl},
  journal   = {Biomolecules \& Therapeutics},
  year      = {2009},
  volume    = {17},
  number    = {3},
  pages     = {219--240},
  doi       = {10.4062/biomolther.2009.17.3.219},
  url       = {https://doi.org/10.4062/biomolther.2009.17.3.219}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201233
201311
201911
202211
202611

Its field-weighted citation impact is 1.06: it has been cited 1.06 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways

  • NF-κB signaling
  • NF-κB inhibitors
  • IKKβ
  • bortezomib
  • proteasome inhibitors
  • kinase inhibitors
  • inflammation
  • hepatocellular carcinoma

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Lee, C., & Kim, S. (2009). NF-κB and Therapeutic Approach. Biomolecules & Therapeutics, 17(3), 219–240. https://doi.org/10.4062/biomolther.2009.17.3.219

How many times has this paper been cited?

14 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Biomolecules & Therapeutics.

Who wrote this paper?

Chang‐Hoon Lee, Soo‐Youl Kim.

What is the DOI of this paper?

10.4062/biomolther.2009.17.3.219. The permanent link is https://doi.org/10.4062/biomolther.2009.17.3.219.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.